DrugPatentWatch Database Preview
Patent: 8,771,960
» See Plans and Pricing
Summary for Patent: 8,771,960
Title: | Method for producing protein libraries and for selecting proteins from said libraries |
Abstract: | The invention relates to a method for the production of a protein library, in particular an antibody library, which is highly diverse and for the selection of proteins, in particular antibodies, therefrom. |
Inventor(s): | Breitling; Frank (Heidelberg, DE), Moldenhauer; Gerhard (Heidelberg, DE), Poustka; Annemarie (Heidelberg, DE), Kuhlwein; Thorsten (Viernheim, DE), Luttgau; Sandra (Dossenheim, DE) |
Assignee: | Deutsches Krebsforschungszentrum (Heidelburg, DE) |
Application Number: | 10/491,653 |
Patent Claims: | see list of patent claims |
Details for Patent 8,771,960
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | Deutsches Krebsforschungszentrum (Heidelburg, DE) | 2021-10-01 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | Deutsches Krebsforschungszentrum (Heidelburg, DE) | 2021-10-01 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Deutsches Krebsforschungszentrum (Heidelburg, DE) | 2021-10-01 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,771,960
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 03029458 | Start Trial |
United States of America | 2005059082 | Start Trial |
Portugal | 1298207 | Start Trial |
Portugal | 1652920 | Start Trial |
Japan | 2005503826 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |